leadf
logo-loader

Pharma & Biotech

Add to MyProactive
Health

Kazia Therapeutics has a unique PI3K inhibitor for brain tumors:...

Kazia and its collaborators are currently running six clinical studies of paxalisib across multiple...

Chimeric Therapeutics Limited - Chimeric Therapeutics to list on Monday after being swamped by IPO investor support Health Chimeric Therapeutics lists on ASX after being swamped by IPO...
1 day, 20 hours ago
Guess - Coffee with Samso: 3D Medical Imaging - taking health care to next dimension, Singular Health Group Finance Coffee with Samso: 3D Medical Imaging - taking health care to next...
4 days ago
Nanollose Ltd - Health Nanollose non-executive director demonstrates confidence in...
4 days, 22 hours ago
Orthocell Ltd - Orthocell's Paul Anderson hails FDA approval for dental bone and tissue regeneration product Health Orthocell's Paul Anderson hails FDA approval for dental bone and...
5 days ago
Paradigm Biopharmaceuticals Ltd - Paradigm Biopharmaceuticals lays out roadmap for the future at JP Morgan Healthcare Conference
5 days, 16 hours ago
Orthocell Ltd - Orthocell soars on receiving FDA clearance to supply CelGro product in US market
5 days, 20 hours ago
Dampier Gold - Tony Locantro gives an insight into his 2021 stock picking strategy
5 days, 23 hours ago
Nanollose Ltd - Nanollose and Grasim Industries (Birla Cellulose) file joint patent application for innovative tree-free fibre technology
6 days, 18 hours ago
Nanollose Ltd - Nanollose says joint patent application for lyocell is 'great step forward'
6 days, 21 hours ago
Acrux - Acrux receives FDA approval for generic testosterone topical solution
1 week, 1 day ago
Orthocell Ltd -
1 week, 1 day ago
esense-Lab Ltd -
1 week, 1 day ago
Neuren Pharmaceuticals Ltd -
1 week, 1 day ago
Imugene Ltd - Imugene completes recruitment to HER-VAXX Phase 2 gastric cancer trial
1 week, 6 days ago
Kazia Therapeutics Ltd - Kazia Therapeutics’s GBM AGILE pivotal study commences recruitment to the paxalisib arm
1 week, 6 days ago
Anteris Technologies Ltd - Anteris Technolgoies Ltd unveils an up to $20 million funding package to develop DurAVR™, its 3D single-piece aortic valve for aortic stenosis
2 weeks ago
Paradigm Biopharmaceuticals Ltd - Paradigm Biopharmaceuticals to present at the annual J.P. Morgan healthcare conference next week
2 weeks ago
PharmAust Ltd - PharmAust agrees to extension of MPL pre-clinical investigations
2 weeks, 1 day ago
Kazia Therapeutics Ltd - Kazia Therapeutics lays solid foundation for strong newsflow in 2021
2 weeks, 1 day ago